Nozomu Muraishi

发表

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma

J. Shindoh, Yoshiyuki Suzuki, M. Hashimoto, 2022, Oncology.

Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment

J. Shindoh, Yoshiyuki Suzuki, I. Yasuda, 2021, Internal medicine.

The useful predictors of zinc deficiency for the management of chronic liver disease

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2022, Journal of Gastroenterology.

Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2021, Oncology.

Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2022, Hepatology communications.

A case of drug-induced acute liver failure caused by corticosteroids

Yoshiyuki Suzuki, K. Kinowaki, M. Kobayashi, 2022, Clinical Journal of Gastroenterology.

Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease

J. Shindoh, Yoshiyuki Suzuki, M. Hashimoto, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment

J. Shindoh, Yoshiyuki Suzuki, M. Hashimoto, 2021, Oncology.

An encapsulated bulky abdominal abscess due to amoeba

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2021, Clinical Journal of Gastroenterology.

Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment

J. Shindoh, Yoshiyuki Suzuki, M. Hashimoto, 2020, Oncology.

Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-years

Yoshiyuki Suzuki, K. Kinowaki, M. Kobayashi, 2020, Internal medicine.

A case of pancreatic arteriovenous malformation caused acute pancreatitis

T. Fujii, J. Imura, I. Yasuda, 2020, Clinical Journal of Gastroenterology.

The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis

J. Shindoh, Yoshiyuki Suzuki, I. Yasuda, 2022, Oncology.

Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease

Yoshiyuki Suzuki, M. Kobayashi, K. Ikeda, 2022, Hepatology International.

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

T. Takahara, M. Minemura, K. Tajiri, 2023, BMC Gastroenterology.

A ruptured sarcomatoid hepatocellular carcinoma treated with combined immunotherapy

Shinichi Tanaka, K. Tajiri, Aiko Murayama, 2023, Clinical Journal of Gastroenterology.

A Case of Wilson's Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis.

T. Takahara, M. Minemura, K. Tajiri, 2024, Internal medicine.

Impact of post‐progression survival in second‐line treatment with molecular target agents for unresectable hepatocellular carcinoma

K. Tajiri, Aiko Murayama, Nozomu Muraishi, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.